Index -
P/E -
EPS (ttm) -25.66
Insider Own 27.10%
Shs Outstand 5.74M
Perf Week 7.02%
Market Cap 78.17M
Forward P/E -
EPS next Y -3.09
Insider Trans -0.77%
Shs Float 4.20M
Perf Month 30.23%
Income -133.16M
PEG -
EPS next Q -1.99
Inst Own 42.26%
Short Float 12.37%
Perf Quarter 45.26%
Sales 100.44M
P/S 0.78
EPS this Y 90.29%
Inst Trans 19.12%
Short Ratio 4.72
Perf Half Y -1.44%
Book/sh -15.77
P/B -
EPS next Y 51.20%
ROA -80.34%
Short Interest 0.52M
Perf Year -21.02%
Cash/sh 11.22
P/C 1.16
EPS next 5Y -
ROE -2014.86%
52W Range 6.50 - 39.50
Perf YTD 1.64%
Dividend Est. 2.00 (15.35% )
P/FCF -
EPS past 5Y 13.12%
ROI -
52W High -67.01%
Beta 0.54
Dividend TTM -
Quick Ratio 0.50
Sales past 5Y 25.21%
Gross Margin 82.70%
52W Low 100.46%
ATR (14) 1.05
Dividend Ex-Date -
Current Ratio 0.59
EPS Y/Y TTM -38.55%
Oper. Margin -118.88%
RSI (14) 61.81
Volatility 8.76% 10.15%
Employees 225
Debt/Eq -
Sales Y/Y TTM 2111.34%
Profit Margin -132.58%
Recom 2.50
Target Price 14.75
Option/Short No / Yes
LT Debt/Eq -
EPS Q/Q 82.11%
Payout -
Rel Volume 0.58
Prev Close 12.51
Sales Surprise 40.23%
EPS Surprise -55.23%
Sales Q/Q 1779.79%
Earnings Nov 12 AMC
Avg Volume 110.14K
Price 13.03
SMA20 7.96%
SMA50 29.48%
SMA200 7.60%
Trades
Volume 64,240
Change 4.16%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-09-23 Downgrade
Mizuho
Buy → Neutral
$31 → $1
Nov-09-23 Downgrade
H.C. Wainwright
Buy → Neutral
Nov-09-23 Downgrade
Evercore ISI
Outperform → In-line
Jul-20-22 Downgrade
Citigroup
Neutral → Sell
$8 → $3
Jul-13-22 Downgrade
Stifel
Buy → Hold
$16 → $5
Jul-13-22 Downgrade
JP Morgan
Overweight → Neutral
$10
May-10-22 Downgrade
Citigroup
Buy → Neutral
$15 → $8
May-13-21 Upgrade
JP Morgan
Neutral → Overweight
$23 → $29
Dec-09-20 Downgrade
Citigroup
Buy → Neutral
$20 → $27
Dec-08-20 Reiterated
H.C. Wainwright
Buy
$28 → $31
Nov-10-20 Reiterated
H.C. Wainwright
Buy
$26 → $28
Jun-30-20 Initiated
Evercore ISI
Outperform
Jun-15-20 Initiated
H.C. Wainwright
Buy
$25
Apr-23-20 Upgrade
Citigroup
Neutral → Buy
$14
Nov-08-19 Downgrade
JP Morgan
Overweight → Neutral
$43 → $22
Sep-27-19 Downgrade
Goldman
Neutral → Sell
$14 → $9
Sep-16-19 Downgrade
Jefferies
Buy → Hold
$32 → $15
Jun-04-19 Upgrade
Citigroup
Sell → Neutral
$23 → $24
May-30-19 Initiated
ROTH Capital
Buy
May-23-19 Initiated
Stifel
Buy
Show Previous Ratings
Dec-04-24 07:00AM
Dec-03-24 07:00AM
Nov-27-24 04:01PM
Nov-13-24 04:01PM
(Business Wire) +22.19%
-10.45%
Nov-12-24 05:15PM
04:13PM
Loading…
04:13PM
(Associated Press Finance)
04:01PM
Nov-05-24 04:01PM
Oct-15-24 12:00PM
Oct-04-24 04:01PM
Sep-30-24 03:16AM
Sep-13-24 07:02PM
(GuruFocus.com) +20.30%
-11.52%
Sep-06-24 04:01PM
(Business Wire) -5.30%
-5.28%
Sep-04-24 04:01PM
(Business Wire) +32.89%
+10.50%
Sep-03-24 04:16PM
06:10PM
Loading…
Aug-12-24 06:10PM
05:07PM
(Associated Press Finance)
05:00PM
Aug-07-24 04:01PM
Jul-19-24 06:12AM
(Pharmaceutical Technology)
Jul-17-24 04:13PM
(Pharmaceutical Technology)
-12.82%
09:00AM
07:00AM
Jul-16-24 07:00AM
Jul-15-24 12:00PM
Jul-05-24 04:01PM
Jul-03-24 07:57PM
Jun-21-24 04:01PM
Jun-17-24 08:00AM
Jun-12-24 07:00AM
07:00AM
Loading…
Jun-11-24 07:00AM
Jun-07-24 04:01PM
Jun-05-24 04:01PM
May-29-24 04:01PM
May-20-24 11:57AM
09:25AM
May-09-24 10:57PM
05:15PM
04:17PM
(Associated Press Finance)
04:01PM
May-03-24 04:01PM
Apr-05-24 04:01PM
Mar-28-24 01:53PM
09:40AM
08:40AM
(Associated Press Finance)
08:30AM
Feb-29-24 09:05AM
Feb-28-24 04:30PM
Feb-14-24 09:00AM
Jan-31-24 06:30PM
Jan-11-24 01:26AM
01:26AM
Jan-08-24 09:00AM
08:00AM
Jan-04-24 04:01PM
Dec-20-23 04:01PM
Dec-11-23 12:00PM
Dec-01-23 04:01PM
Nov-29-23 06:05PM
Nov-24-23 12:29PM
Nov-22-23 04:01PM
09:14AM
Nov-10-23 04:01PM
Nov-09-23 08:23AM
06:40AM
Nov-08-23 05:35PM
Nov-05-23 12:50PM
Nov-02-23 05:42AM
02:25AM
(Thomson Reuters StreetEvents)
Nov-01-23 08:35AM
(Associated Press Finance)
08:30AM
Oct-06-23 04:01PM
Sep-21-23 09:19AM
Sep-19-23 04:01PM
Sep-01-23 04:01PM
Aug-31-23 04:01PM
Aug-13-23 10:44AM
Aug-08-23 05:30PM
04:18PM
04:01PM
Aug-04-23 04:01PM
Aug-01-23 04:01PM
Jul-31-23 04:01PM
Jul-29-23 11:07AM
Jul-17-23 07:29AM
Jul-07-23 04:01PM
(Business Wire) +11.45%
+5.41%
Jun-16-23 06:05AM
Jun-07-23 04:01PM
Jun-05-23 09:00AM
Jun-02-23 04:01PM
May-18-23 07:09AM
May-08-23 05:15PM
04:12PM
04:01PM
May-07-23 08:59AM
May-05-23 04:01PM
May-01-23 04:01PM
Apr-16-23 12:08PM
Mar-31-23 04:01PM
Mar-24-23 09:35AM
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Henrich Jill EVP, Chief Regulatory Officer Nov 18 '24 Sale 11.20 1,000 11,198 19,378 Nov 20 06:05 PM Hyllengren Eric J EVP, CFO and COO Nov 18 '24 Sale 11.20 1,364 15,274 23,392 Nov 20 06:04 PM Nguyen AnhCo President and CEO Nov 18 '24 Sale 11.20 1,664 18,633 77,454 Nov 20 06:04 PM Nguyen AnhCo Officer Nov 18 '24 Proposed Sale 12.00 1,857 22,284 Nov 18 05:58 PM Murugan Amar Former Officer Nov 18 '24 Proposed Sale 12.00 1,342 16,104 Nov 18 05:56 PM Hyllengren Eric J Officer Nov 18 '24 Proposed Sale 12.00 1,517 18,204 Nov 18 05:55 PM Henrich Jill Officer Nov 18 '24 Proposed Sale 12.00 1,112 13,344 Nov 18 05:54 PM Touchon Pascal President and CEO Aug 16 '24 Sale 6.63 3,038 20,139 70,127 Aug 20 06:27 PM Nguyen AnhCo EVP, Chief Sci. & Tech Officer Aug 16 '24 Sale 6.63 1,821 12,072 34,118 Aug 20 06:27 PM Murugan Amar EVP, Chief Legal Officer Aug 16 '24 Sale 6.63 1,158 7,677 26,827 Aug 20 06:27 PM Hyllengren Eric J EVP, CFO Aug 16 '24 Sale 6.63 1,070 7,093 24,756 Aug 20 06:27 PM Henrich Jill EVP, Global Head RA & Quality Aug 16 '24 Sale 6.63 963 6,384 20,378 Aug 20 06:26 PM Touchon Pascal Director Aug 16 '24 Proposed Sale 8.02 3,525 28,270 Aug 16 04:12 PM Nguyen AnhCo Officer Aug 16 '24 Proposed Sale 8.02 2,114 16,954 Aug 16 04:10 PM Murugan Amar Officer Aug 16 '24 Proposed Sale 8.02 1,342 10,763 Aug 16 04:09 PM Hyllengren Eric J Officer Aug 16 '24 Proposed Sale 8.02 1,239 9,937 Aug 16 04:08 PM Henrich Jill Officer Aug 16 '24 Proposed Sale 8.02 1,113 8,926 Aug 16 04:06 PM Touchon Pascal President and CEO May 16 '24 Sale 0.62 81,506 50,289 1,829,146 May 20 08:34 PM Nguyen AnhCo EVP, Chief Sci. & Tech Officer May 16 '24 Sale 0.62 42,899 26,469 898,498 May 20 08:34 PM Murugan Amar EVP, Chief Legal Officer May 16 '24 Sale 0.62 32,401 19,991 695,120 May 20 08:33 PM Hyllengren Eric J EVP, CFO May 16 '24 Sale 0.62 28,648 17,676 645,671 May 20 08:33 PM Henrich Jill EVP, Global Head RA & Quality May 16 '24 Sale 0.62 25,750 15,888 529,251 May 20 08:32 PM Touchon Pascal President and CEO Mar 04 '24 Sale 0.72 24,844 17,888 1,910,652 Mar 06 06:19 PM Nguyen AnhCo EVP, Chief Sci. & Tech Officer Mar 04 '24 Sale 0.72 10,746 7,737 941,397 Mar 06 06:18 PM Murugan Amar EVP, Chief Legal Officer Mar 04 '24 Sale 0.72 10,044 7,232 727,521 Mar 06 06:18 PM Henrich Jill EVP, Global Head RA & Quality Mar 04 '24 Sale 0.72 3,879 2,793 555,001 Mar 06 06:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite